These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 190074)

  • 1. Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man.
    Bomboy JD; Lewis SB; Lacy WW; Sinclair-Smith BC; Liljenquist JE
    Diabetes; 1977 Mar; 26(3):177-4. PubMed ID: 190074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men.
    Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW
    J Clin Invest; 1974 Jan; 53(1):198-204. PubMed ID: 4357612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glucagon on lipolysis and ketogenesis in normal and diabetic men.
    Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW
    J Clin Invest; 1974 Jan; 53(1):190-7. PubMed ID: 4808635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.
    Saccà L; Cicala M; Trimarco B; Ungaro B; Vigorito C
    J Clin Invest; 1982 Jul; 70(1):117-26. PubMed ID: 6123524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of physiologic hyperglucagonemia on basal and insulin-inhibited splanchnic glucose output in normal man.
    Felig P; Wahren J; Hendler R
    J Clin Invest; 1976 Sep; 58(3):761-5. PubMed ID: 956401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-glucagon interaction in controlling splanchnic glucose production in normal man.
    Bomboy JD; Lewis SB; Sinclair-Smith BC; Lacy WW; Liljenquist JE
    J Clin Endocrinol Metab; 1977 Mar; 44(3):474-80. PubMed ID: 838848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.
    Liljenquist JE; Mueller GL; Cherrington AD; Keller U; Chiasson J-L ; Perry JM; Lacy WW; Rabinowitz D
    J Clin Invest; 1977 Feb; 59(2):369-74. PubMed ID: 833282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cyclic AMP in glucagon-induced stimulation of hepatic glucose output in man.
    Grill V; Cerasi E; Wahren J
    Scand J Clin Lab Invest; 1979 Dec; 39(8):689-96. PubMed ID: 231294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia per se (insulin and glucagon withdrawn) can inhibit hepatic glucose production in man.
    Liljenquist JE; Mueller GL; Cherrington AD; Perry JM; Rabinowitz D
    J Clin Endocrinol Metab; 1979 Jan; 48(1):171-5. PubMed ID: 422700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for an augmented glucagon dependence of hepatic glucose production in cirrhosis of the liver.
    Keller U; Sonnenberg GE; Burckhardt D; Perruchoud A
    J Clin Endocrinol Metab; 1982 May; 54(5):961-8. PubMed ID: 6120952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin synthesis inhibitors impair hepatic glucose production in response to glucagon and epinephrine stimulation.
    Miller JD; Ganguli S; Sperling MA
    Diabetes; 1983 May; 32(5):439-44. PubMed ID: 6301913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient hepatic response to glucagon in man: role of insulin and hyperglycemia.
    Ferrannini E; DeFronzo RA; Sherwin RS
    Am J Physiol; 1982 Feb; 242(2):E73-81. PubMed ID: 7039338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals.
    Matsuda M; Defronzo RA; Glass L; Consoli A; Giordano M; Bressler P; Delprato S
    Metabolism; 2002 Sep; 51(9):1111-9. PubMed ID: 12200754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glucocorticoids on hepatic sensitivity to insulin and glucagon in man.
    Dirlewanger M; Schneiter PH; Paquot N; Jequier E; Rey V; Tappy L
    Clin Nutr; 2000 Feb; 19(1):29-34. PubMed ID: 10700531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism.
    Perez G; Ungaro B; Covelli A; Morrone G; Lombardi G; Scopacasa F; Rossi R
    J Clin Endocrinol Metab; 1980 Nov; 51(5):972-7. PubMed ID: 7419694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent effect of sustained hyperglucagonemia on glucose production in man.
    Rizza RA; Gerich JE
    J Clin Endocrinol Metab; 1979 Feb; 48(2):352-5. PubMed ID: 429489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.